You are here

P&T News

March 28

Threat highest in Southeast, southern Atlantic Coast, and southern California
New Leapfrog methodology and grades due soon
PARP inhibitor improves progression-free survival
Prevention, screening, treatment, and creative financing for medication sought

March 27

Devices may not power up, charge, or deliver shock therapy
Scientists find previously unknown genetic changes that predispose patients to glioma
New patent battle focuses on Sovaldi, which costs thousands of dollars for a course
Developers to file NDA in second half of 2017
Controversies are critiqued and data-derived recommendations are proposed

March 24

The human anti-PD-L1 antibody is the first therapy for this rare skin cancer
CTSA program paves way for nationwide single IRB model
MRIs more dependable than patient preference to determine best approach
John Hopkins experts call for early-detection strategies
Scientists working to develop the potential of nuclear receptors

March 23

Ocrevus and Dupixent set to make a splash
Retrospective data must be confirmed in clinical trials
Health care job growth is down 23% compared with last year
Senators complain about drug makers’ abuses

Pages